Matrix metalloproteinases as modulators of inflammation and innate immunity (original) (raw)

• Velasco, G. et al. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J. Biol. Chem. 274, 4570–4576 (1999).
  Article CAS PubMed Google Scholar
• Bode, W., Gomis-Ruth, F. X. & Stockler, W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 331, 134–140 (1993).
  Article CAS PubMed Google Scholar
• Massova, I., Kotra, L. P., Fridman, R. & Mobashery, S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 12, 1075–1095 (1998).
  Article CAS PubMed Google Scholar
• Shapiro, S. D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10, 602–608 (1998).
  Article CAS PubMed Google Scholar
• Van Wart, H. E. & Birkedal-Hansen, H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl Acad. Sci. USA 87, 5578–5582 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Strongin, A. Y. et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331–5338 (1995).
  Article CAS PubMed Google Scholar
• Hernandez-Barrantes, S. et al. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275, 12080–12089 (2000).
  Article CAS PubMed Google Scholar
• Wang, Z., Juttermann, R. & Soloway, P. D. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411–26415 (2000).
  Article CAS PubMed Google Scholar
• Caterina, J. J. et al. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2 (Timp-2) gene alters proMMP-2 activation. J. Biol. Chem. 275, 26416–26422 (2000).
  Article CAS PubMed Google Scholar
• Yang, Z., Strickland, D. K. & Bornstein, P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J. Biol. Chem. 276, 8403–8408 (2001).
  Article CAS PubMed Google Scholar
• Barmina, O. Y. et al. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J. Biol. Chem. 274, 30087–30093 (1999).
  Article CAS PubMed Google Scholar
• Weiss, S. J., Peppin, G., Ortiz, X., Ragsdale, C. & Test, S. T. Oxidative autoactivation of latent collagenase by human neutrophils. Science 227, 747–749 (1985).
  Article CAS PubMed Google Scholar
• Peppin, G. J. & Weiss, S. J. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl Acad. Sci. USA 83, 4322–4326 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Fu, X., Kassim, S. Y., Parks, W. C. & Heinecke, J. W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276, 41279–41287 (2001).
  Article CAS PubMed Google Scholar
• Gu, Z. et al. _S_-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186–1190 (2002).
  Article CAS PubMed Google Scholar
• Fu, X., Kassim, S. Y., Parks, W. C. & Heinecke, J. W. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J. Biol. Chem. 278, 28403–28409 (2003). References 12–16 show that reactive metabolites, often leukocyte-generated oxidants, can both activate and inactivate the catalytic activity of MMPs. Although these mechanisms have not yet been shown in vivo , they are probably important for the regulation of MMPs in inflammation.
  Article CAS PubMed Google Scholar
• Sternlicht, M. D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463–516 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Mackay, A. R., Hartzler, J. L., Pelina, M. D. & Thorgeirsson, U. P. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. Biol. Chem. 265, 21929–21934 (1990).
  CAS PubMed Google Scholar
• Halpert, I. et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl Acad. Sci. USA 93, 9748–9753 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Brooks, P. C. et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3 . Cell 85, 683–693 (1996).
  Article CAS PubMed Google Scholar
• Dumin, J. A. et al. Procollagenase-1 (matrix metalloproteinase-1) binds the integrin α2β1 upon release from keratinocytes migrating on type I collagen. J. Biol. Chem. 276, 29368–29374 (2001).
  Article CAS PubMed Google Scholar
• Stricker, T. P. et al. Structural analysis of the α2 integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J. Biol. Chem. 276, 29375–29381 (2001).
  Article CAS PubMed Google Scholar
• Yu, Q. & Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163–176 (2000).
  PubMed PubMed Central Google Scholar
• Yu, W. H. & Woessner, J. F. Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 275, 4183–4191 (2000).
  Article CAS PubMed Google Scholar
• Yu, W. H., Woessner, J. F. Jr, McNeish, J. D. & Stamenkovic, I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307–323 (2002). This paper provides a good example of how a 'secreted' MMP is bound to and compartmentalized by a cell-surface molecule.
  Article CAS PubMed PubMed Central Google Scholar
• Gross, J. & Lapiere, C. M. Collagenolytic activity in amphipian tissues: a tissue culture assay. Proc. Natl Acad. Sci. USA 48, 1014–1022 (1962).
  Article CAS PubMed PubMed Central Google Scholar
• McQuibban, G. A. et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202–1206 (2000). This paper shows how exosite scanning and yeast two-hybrid techniques can be used to identify novel MMP substrates: in this case, chemokines. Together with other studies by these investigators (references 54 and 55), this study provides evidence that MMP proteolysis directly regulates chemokine activity.
  Article CAS PubMed Google Scholar
• Guo, L. et al. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases. Mol. Cell. Proteomics 1, 30–36 (2002).
  Article CAS PubMed Google Scholar
• Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S. & Overall, C. M. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl Acad. Sci. USA 101, 6917–6922 (2004). This paper describes a proteomics study using state-of-the-art technology to identify MMP substrates. This knowledge is essential for understanding the function of these enzymes in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• McCawley, L. J. & Matrisian, L. M. Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534–540 (2001).
  Article CAS PubMed Google Scholar
• Holmbeck, K. et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81–92 (1999).
  Article CAS PubMed Google Scholar
• Zhou, Z. et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl Acad. Sci. USA 97, 4052–4057 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hotary, K., Allen, E., Punturieri, A., Yana, I. & Weiss, S. J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149, 1309–1323 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hotary, K. B. et al. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 195, 295–308 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Filippov, S. et al. Matrilysin-dependent elastolysis by human macrophages. J. Exp. Med. 198, 925–935 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Opdenakker, G., Van den Steen, P. E. & Van Damme, J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22, 571–579 (2001).
  Article CAS PubMed Google Scholar
• Nathan, C. Points of control in inflammation. Nature 420, 846–852 (2002).
  Article CAS PubMed Google Scholar
• Lee, H. M. et al. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J. Periodontol. 75, 453–463 (2004).
  Article CAS PubMed Google Scholar
• Whelan, C. J. Metalloprotease inhibitors as anti-inflammatory agents: an evolving target? Curr. Opin. Investig. Drugs 5, 511–516 (2004).
  CAS PubMed Google Scholar
• Sierevogel, M. J., Pasterkamp, G., de Kleijn, D. P. & Strauss, B. H. Matrix metalloproteinases: a therapeutic target in cardiovascular disease. Curr. Pharm. Des. 9, 1033–1040 (2003).
  Article CAS PubMed Google Scholar
• Itoh, T. et al. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J. Immunol. 169, 2643–2647 (2002).
  Article CAS PubMed Google Scholar
• Mudgett, J. S. et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41, 110–121 (1998).
  Article CAS PubMed Google Scholar
• Parks, W. C. Matrix metalloproteinases in repair. Wound Repair Regen. 7, 423–432 (1999).
  Article CAS PubMed Google Scholar
• Pilcher, B. K. et al. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445–1457 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Dunsmore, S. E. et al. Matrilysin expression and function in airway epithelium. J. Clin. Invest. 102, 1321–1331 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• McGuire, J. K., Li, Q. & Parks, W. C. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am. J. Pathol. 162, 1831–1843 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Legrand, C. et al. Airway epithelial cell migration dynamics: MMP-9 role in cell–extracellular matrix remodeling. J. Cell Biol. 146, 517–529 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Betsuyaku, T., Fukuda, Y., Parks, W. C., Shipley, J. M. & Senior, R. M. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 157, 525–535 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Saarialho-Kere, U. K., Crouch, E. C. & Parks, W. C. Matrix metalloproteinase matrilysin is constitutively expressed in human exocrine epithelium. J. Invest. Dermatol. 105, 190–196 (1995).
  Article CAS PubMed Google Scholar
• Ouellette, A. J. & Selsted, M. E. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J. 10, 1280–1289 (1996).
  Article CAS PubMed Google Scholar
• Wilson, C. L. et al. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113–117 (1999). This study identifies α-defensins as a new class of substrates for MMPs and demonstrates a specific role for MMP7 in innate immunity.
  Article CAS PubMed Google Scholar
• Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497 (1998).
  Article CAS PubMed Google Scholar
• Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M. & Matrisian, L. M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9, 1441–1447 (1999). This study establishes that FASL is a substrate for MMP7. MMP-mediated apoptosis, through the activation of FASL, might provide a mechanism for bacterial clearance, as indicated in figure 4.
  Article CAS PubMed Google Scholar
• Hartzell, W. & Shapiro, S. D. Macrophage elastase prevents Gemella morbillorum infection and improves outcome following murine bone marrow transplantation. Chest 116, 31S–32S (1999).
  Article CAS PubMed Google Scholar
• López-Boado, Y. S. et al. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J. Cell Biol. 148, 1305–1315 (2000).
  Article PubMed PubMed Central Google Scholar
• López-Boado, Y. S., Wilson, C. L. & Parks, W. C. Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J. Biol. Chem. 276, 41417–41423 (2001).
  Article PubMed Google Scholar
• Wilson, C. L. & Matrisian, L. M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 28, 123–136 (1996).
  Article CAS PubMed Google Scholar
• Kagnoff, M. F. & Eckmann, L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 100, 6–10 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Borish, L. C. & Steinke, J. W. Cytokines and chemokines. J. Allergy Clin. Immunol. 111, S460–S475 (2003).
  Article CAS PubMed Google Scholar
• McQuibban, G. A. et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160–1167 (2002).
  CAS PubMed Google Scholar
• McQuibban, G. A. et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503–43508 (2001).
  Article CAS PubMed Google Scholar
• Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J. & Opdenakker, G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood 96, 2673–2681 (2000).
  CAS PubMed Google Scholar
• Van Den Steen, P. E. et al. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270, 3739–3749 (2003).
  Article CAS PubMed Google Scholar
• Corry, D. B. et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nature Immunol. 3, 347–353 (2002). One the first papers to show that MMPs establish chemokine gradients in vivo . Reference 71 is a follow-up to these studies.
  Article CAS Google Scholar
• Pruijt, J. F. et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc. Natl Acad. Sci. USA 96, 10863–10868 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Q., Park, P. W., Wilson, C. L. & Parks, W. C. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635–646 (2002). This paper describes a mechanism in which three epithelial products — an MMP, a CXC-chemokine and a proteoglycan — interact to control and coordinate acute inflammation at sites of injury.
  Article CAS PubMed Google Scholar
• Zhang, K. et al. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nature Neurosci. 6, 1064–1071 (2003). This interesting study shows that MMP2 secreted by HIV-infected macrophages cleaves CXCL12 to generate a potent neurotoxin.
  Article CAS PubMed Google Scholar
• Balbin, M. et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nature Genet. 35, 252–257 (2003).
  Article CAS PubMed Google Scholar
• Khandaker, M. H. et al. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-α-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93, 2173–2185 (1999).
  CAS PubMed Google Scholar
• Li, X. Y., Donaldson, K., Brown, D. & Macnee, W. The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation. Am. J. Resp. Cell Mol. Biol. 13, 185–195 (1995).
  Article CAS Google Scholar
• Corry, D. B. et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J. 18, 995–997 (2004).
  Article CAS PubMed Google Scholar
• Haro, H. et al. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J. Clin. Invest. 105, 133–141 (2000). Together with reference 102, this paper shows that specific MMPs function as crucial components of an inflammatory network between different cell types, using a model of tissue resorption.
  Article CAS PubMed PubMed Central Google Scholar
• Hautamaki, R. D., Kobayashi, D. K., Senior, R. M. & Shapiro, S. D. Requirement for macrophage elastase for cigarette smoke-induced emphysema. Science 277, 2002–2004 (1997).
  Article CAS PubMed Google Scholar
• Nelissen, I. et al. Gelatinase B/matrix metalloproteinase-9 cleaves interferon-β and is a target for immunotherapy. Brain 126, 1371–1381 (2003).
  Article PubMed Google Scholar
• Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2, 737–744 (2000).
  Article CAS PubMed Google Scholar
• Suzuki, M., Raab, G., Moses, M. A., Fernandez, C. A. & Klagsbrun, M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272, 31730–31737 (1997).
  Article CAS PubMed Google Scholar
• Levi, E. et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Natl Acad. Sci. USA 93, 7069–7074 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Kulkarni, A. B. & Karlsson, S. Transforming growth factor-β 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143, 3–9 (1993).
  CAS PubMed PubMed Central Google Scholar
• Munger, J. S. et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319–328 (1999).
  Article CAS PubMed Google Scholar
• Maeda, S., Dean, D. D., Gomez, R., Schwartz, Z. & Boyan, B. D. The first stage of transforming growth factor β1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif. Tissue Int. 70, 54–65 (2002).
  Article CAS PubMed Google Scholar
• Karsdal, M. A. et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277, 44061–44067 (2002).
  Article CAS PubMed Google Scholar
• Fantuzzi, G. et al. Response to local inflammation of IL-1β-converting enzyme-deficient mice. J. Immunol. 158, 1818–1824 (1997).
  CAS PubMed Google Scholar
• Schonbeck, U., Mach, F. & Libby, P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 161, 3340–3346 (1998).
  CAS PubMed Google Scholar
• Ito, A. et al. Degradation of interleukin 1β by matrix metalloproteinases. J. Biol. Chem. 271, 14657–14660 (1996).
  Article CAS PubMed Google Scholar
• Gearing, A. J. H. et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555–557 (1994).
  Article CAS PubMed Google Scholar
• Black, R. A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729–733 (1997).
  Article CAS PubMed Google Scholar
• Moss, M. L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385, 733–736 (1997).
  Article CAS PubMed Google Scholar
• Mohan, M. J. et al. The tumor necrosis factor-α converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 41, 9462–9469 (2002).
  Article CAS PubMed Google Scholar
• English, W. R. et al. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-α convertase activity but does not activate pro-MMP2. J. Biol. Chem. 275, 14046–14055 (2000).
  Article CAS PubMed Google Scholar
• Visse, R. & Nagase, H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827–839 (2003).
  Article CAS PubMed Google Scholar
• Qi, J. H. et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nature Med. 9, 407–415 (2003).
  Article CAS PubMed Google Scholar
• Seo, D. W. et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114, 171–180 (2003).
  Article CAS PubMed Google Scholar
• Oh, J. et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789–800 (2001).
  Article CAS PubMed Google Scholar
• Coussens, L. M., Fingleton, B. & Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387–2392 (2002).
  Article CAS PubMed Google Scholar
• Overall, C. M. & Lopez-Otin, C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nature Rev. Cancer 2, 657–672 (2002).
  Article CAS Google Scholar
• Mott, J. D. et al. Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor. J. Biol. Chem. 275, 1384–1390 (2000).
  Article CAS PubMed Google Scholar
• Belaaouaj, A. et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nature Med. 4, 615–618 (1998).
  Article CAS PubMed Google Scholar
• Liu, Z. et al. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102, 647–655 (2000). Using an experimental model of blister formation, this paper shows that MMP9 contributes to inflammation-mediated tissue damage by cleaving and inactivating the serpin α1-antiproteinase (a potent inhibitor of neutrophil elastase).
  Article CAS PubMed Google Scholar
• Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139, 1861–1872 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sympson, C. J. et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125, 681–693 (1994).
  Article CAS PubMed Google Scholar
• Haro, H. et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J. Clin. Invest. 105, 143–150 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Asahi, M. et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724–7732 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Lelongt, B. et al. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J. Exp. Med. 193, 793–802 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G. & Yong, V. W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 23, 11127–11135 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Churg, A. et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release. Am. J. Respir. Crit. Care Med. 167, 1083–1089 (2003).
  Article PubMed Google Scholar
• Hotary, K. B. et al. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 195, 295–308 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Endo, K. et al. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 278, 40764–40770 (2003).
  Article CAS PubMed Google Scholar
• Koshikawa, N. et al. Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology. FASEB J. 18, 364–366 (2004).
  Article CAS PubMed Google Scholar
• Caterina, J. J. et al. Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J. Biol. Chem. 277, 49598–49604 (2002).
  Article CAS PubMed Google Scholar
• Billinghurst, R. C. et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99, 1534–1545 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Otterness, I. G. et al. Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody. Matrix Biol. 18, 331–341 (1999).
  Article CAS PubMed Google Scholar
• Wu, W. et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum. 46, 2087–2094 (2002).
  Article CAS PubMed Google Scholar
• Hotary, K. B. et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33–45 (2003).
  Article CAS PubMed Google Scholar
• Balbin, M. et al. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem. 276, 10253–10262 (2001).
  Article CAS PubMed Google Scholar
• Cossins, J., Dudgeon, T. J., Catlin, G., Gearing, A. J. & Clements, J. M. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228, 494–498 (1996).
  Article CAS PubMed Google Scholar
• Stolow, M. A. et al. Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol. Biol. Cell 7, 1471–1483 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Clark, H. F. et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13, 2265–2270 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Itoh, T. et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048–1051 (1998).
  CAS PubMed Google Scholar
• Kato, T. et al. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508, 187–190 (2001).
  Article CAS PubMed Google Scholar
• Ohno-Matsui, K. et al. Reduced retinal angiogenesis in MMP-2-deficient mice. Invest. Ophthalmol. Vis. Sci. 44, 5370–5375 (2003).
  Article PubMed Google Scholar
• Berglin, L. et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest. Ophthalmol. Vis. Sci. 44, 403–408 (2003).
  Article PubMed Google Scholar
• Wang, M. et al. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl Acad. Sci. USA 96, 6885–6889 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Warner, R. L. et al. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am. J. Respir. Cell Mol. Biol. 24, 537–544 (2001).
  Article CAS PubMed Google Scholar
• Silence, J., Lupu, F., Collen, D. & Lijnen, H. R. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler. Thromb. Vasc. Biol. 21, 1440–1445 (2001).
  Article CAS PubMed Google Scholar
• Kure, T. et al. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest. Ophthalmol. Vis. Sci. 44, 137–144 (2003).
  Article PubMed Google Scholar
• Dubois, B. et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J. Clin. Invest. 104, 1507–1515 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Dubois, B. et al. Gelatinase B deficiency protects against endotoxin shock. Eur. J. Immunol. 32, 2163–2171 (2002).
  Article CAS PubMed Google Scholar
• Ratzinger, G. et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168, 4361–4371 (2002).
  Article CAS PubMed Google Scholar
• Liu, Z. et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188, 475–482 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Vu, T. H. et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411–422 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481–490 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, C., Sung, H. J., Lessner, S. M., Fini, M. E. & Galis, Z. S. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ. Res. 94, 262–268 (2004).
  Article CAS PubMed Google Scholar
• McMillan, S. J. et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J. Immunol. 172, 2586–2594 (2004).
  Article CAS PubMed Google Scholar
• Cataldo, D. D. et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am. J. Pathol. 161, 491–498 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lanone, S. et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and-12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110, 463–474 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Luttun, A. et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109, 1408–1414 (2004).
  Article CAS PubMed Google Scholar
• Longo, G. M. et al. Matrix metalloproteinase 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110, 625–632 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105, 1641–1649 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Asahi, M. et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681–1689 (2000).
  Article CAS PubMed Google Scholar
• Lambert, V. et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 17, 2290–2292 (2003).
  Article CAS PubMed Google Scholar
• Shipley, J. M., Wesselschmidt, R. L., Kobayashi, D. K., Ley, T. J. & Shapiro, S. D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl Acad. Sci. USA 93, 3942–3946 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Wells, J. E. et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J. Neurosci. 23, 10107–10115 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Warner, R. L. et al. The role of metalloelastase in immune complex-induced acute lung injury. Am. J. Pathol. 158, 2139–2144 (2001).
  Article CAS PubMed PubMed Central Google Scholar